Although these experiments identify host cell expression of CCR2 and tumor cell expression of TRAIL-R and CCL2 as required for this pro-tumorigenic crosstalk between the TRAIL/TRAIL-R and CCL2/CCR2 systems, the source for TRAIL can be many fold. The gene discussed is CCL2; the disease is neoplasm.